Table 2. Summary of remarkable reviews, their countries, number of patients, purpose of review, and results.
| Country | No of Pts | Purpose | Results | |
|---|---|---|---|---|
| Karnad DR | India | 8 | Hemodynamic profiles | 1 hypertensive/tachycardia |
| 7 hypotensive/pulmonary edema/cardiogenic shock | ||||
| 1 mortality | ||||
| Sofer S, et al. | Israel | 32 (children) | Myocardial injury | 13 pt (40%) myocardial damage (high enzymes) |
| 6 pt (18-20%) ECG abnormalities | ||||
| Mazzei de Dàvila CA, et al. | Venzuella | 16 (with LV dysfuction) | Relation between LV dysfunction & Sympathetic activity | All cases with some degree of LV dysfunction have high levels of NE. |
| Abroug F, et al. | Tunisia | 9 (with CHF) | Presentation & Outcomes | All with LV dysfunction (EF: 26 ± 12 %) |
| All with CHF (PCWP: 24 ± 2 mmHg). | ||||
| 8 improved/full recovery | ||||
| 1 mortality | ||||
| Ismail M, et al. | Saudi Arabia | 3800 (all scorpion sting cases) | Antivenome administration & Outcome | The earlier the Anti-venome given the better the outcome. |
| Nigligible CVS manifestations | ||||
| Bawaskar HS, et al. | West india | 658 | Prazocin & Outcome | >20% mortality in pre-Prazocin era |
| <1% mortality after Prazocin |
Notes.
*
Pt = patient / ECG = Electrocardiography / LV = Left Ventricle / NE = Norepinephrin / CHF = Congestive Heart Failure / EF = Ejection Fraction / PCWP = Pulmonary Capillary Wedge Pressure / CVS = Cardio Vascular System.